Monitoring particulate contamination in biopharmaceuticals with FlowCam
2 Oct 2022
Measuring and monitoring particulate matter in injectable therapeutics is essential for biopharmaceutical formulation development, manufacturing, and packaging and is required by regulatory bodies such as the FDA. In this video, learn about the FlowCam range of imaging particle analyzers from Yokogawa Fluid Imaging Technologies. These instruments combine digital imaging, flow cytometry, and microscopy into a single instrument and are designed for superior particle analysis.
About the company

Yokogawa Fluid Imaging Technologies, Inc
Yokogawa Fluid Imaging Technologies is the industry leader in flow imaging microscopy solutions for particle analysis of biologic drug products, oceanographic research, municipal water quality monitoring, and materials characterization.
Our flagship instrument, FlowCam, was originally developed in the mid-1990s at Bigelow Laboratory for Ocean Sciences for studying plankton in ocean water. Commercialized by Fluid Imaging Technologies, FlowCam is designed to combine the benefits of digital imaging, flow cytometry, and microscopy into a single solution. Today we are part of the Life Innovation Business of Yokogawa and headquartered near Portland, Maine. We focus on bringing clarity and focus to the study of subvisible particles in the life sciences across many areas of research. We are committed to developing innovative hardware and software to monitor Earth’s water bodies and drinking water supply for hazardous algae, to help make vaccines and injectable medicines safer, and to improve product quality.
Our team of engineers, application scientists, manufacturing technicians, marketers, and sales application specialists work together to ensure that we are producing quality, cutting-edge technology for our customers. FlowCam instruments have been deployed in over 50 countries, supporting research, development, and environmental monitoring in the life sciences.



